Airway irritability - a burning issue?

Current Opinion in Pharmacology

Volumn 9, Issue 4, 2009, Pages 530-534

  Spina, Domenico ^a   Page, Clive ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RESPIRATORY TRACT AGENT; TACHYKININ RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1; VANILLOID RECEPTOR 1 ANTAGONIST;

ASTHMA; BRONCHUS HYPERREACTIVITY; CLINICAL TRIAL; COUGHING; DRUG TARGETING; GENE EXPRESSION; GENE REGULATORY NETWORK; HUMAN; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; MEDIATOR RELEASE; NONHUMAN; PAIN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; RESPIRATORY TRACT INFLAMMATION; REVIEW; RHINITIS; SENSORY NERVE; SMOOTH MUSCLE; SYSTEMS BIOLOGY;

ANIMALS; ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHIAL HYPERREACTIVITY; HUMANS; INFLAMMATION MEDIATORS; LUNG;

EID: 68849120385     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2009.06.019     Document Type: Review

References (66)

1. Bond R.A., Spina D., Parra S., and Page C.P. Getting to the heart of asthma: can "beta blockers" be useful to treat asthma?. Pharmacol Ther 115 (2007) 360-374
2. Slats A.M., Janssen K., van S.A., van der Plas D.T., Schot R., van den Aardweg J.G., de Jongste J.C., Hiemstra P.S., Mauad T., Rabe K.F., et al. Bronchial inflammation and airway responses to deep inspiration in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 176 (2007) 121-128
3. Van Schoor J., Joos G.F., and Pauwels R.A. Effect of inhaled fluticasone on bronchial responsiveness to neurokinin A in asthma. Eur Respir J 19 (2002) 997-1002
4. Cockcroft D.W., and Davis B.E. Mechanisms of airway hyperresponsiveness. J Allergy Clin Immunol 118 (2006) 551-559
5. Sont J.K., Willems L.N., Bel E.H., van Krieken J.H., Vandenbroucke J.P., and Sterk P.J. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med 159 (1999) 1043-1051
6. An S.S., Bai T.R., Bates J.H., Black J.L., Brown R.H., Brusasco V., Chitano P., Deng L., Dowell M., Eidelman D.H., et al. Airway smooth muscle dynamics: a common pathway of airway obstruction in asthma. Eur Respir J 29 (2007) 834-860
7. Gil F.R., and Lauzon A.M. Smooth muscle molecular mechanics in airway hyperresponsiveness and asthma. Can J Physiol Pharmacol 85 (2007) 133-140
8. Holgate S.T. The epithelium takes centre stage in asthma and atopic dermatitis. Trends Immunol 28 (2007) 248-251
9. Jacobsen E.A., Ochkur S.I., Lee N.A., and Lee J.J. Eosinophils and asthma. Curr Allergy Asthma Rep 7 (2007) 18-26
10. Rosenberg H.F., Phipps S., and Foster P.S. Eosinophil trafficking in allergy and asthma. J Allergy Clin Immunol 119 (2007) 1303-1310
11. Lloyd C.M., and Robinson D.S. Allergen-induced airway remodelling. Eur Respir J 29 (2007) 1020-1032
12. Beier K.C., Kallinich T., and Hamelmann E. T-cell co-stimulatory molecules: novel targets for the treatment of allergic airway disease. Eur Respir J 30 (2007) 383-390
13. Kallinich T., Beier K.C., Wahn U., Stock P., and Hamelmann E. T-cell co-stimulatory molecules: their role in allergic immune reactions. Eur Respir J 29 (2007) 1246-1255
14. Hammad H., and Lambrecht B.N. Lung dendritic cell migration. Adv Immunol 93 (2007) 265-278
15. Spina D., and Page C.P. Pharmacology of airway irritability. Curr Opin Pharmacol 2 (2002) 264-272
16. Undem B.J., Carr M.J., and Kollarik M. Physiology and plasticity of putative cough fibres in the guinea pig. Pulm Pharmacol Ther 15 (2002) 193-198
17. Carr M.J., and Undem B.J. Pharmacology of vagal afferent nerve activity in guinea pig airways. Pulm Pharmacol Ther 16 (2003) 45-52
18. Nilius B., Owsianik G., Voets T., and Peters J.A. Transient receptor potential cation channels in disease. Physiol Rev 87 (2007) 165-217
19. Szallasi A., Cortright D.N., Blum C.A., and Eid S.R. The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept. Nat Rev Drug Discov 6 (2007) 357-372
20. Patapoutian A., Tate S., and Woolf C.J. Transient receptor potential channels: targeting pain at the source. Nat Rev Drug Discov 8 (2009) 55-68
21. Groneberg D.A., Niimi A., Dinh Q.T., Cosio B., Hew M., Fischer A., and Chung K.F. Increased expression of transient receptor potential vanilloid-1 in airway nerves of chronic cough. Am J Respir Crit Care Med 170 (2004) 1276-1280
22. Mitchell J.E., Campbell A.P., New N.E., Sadofsky L.R., Kastelik J.A., Mulrennan S.A., Compton S.J., and Morice A.H. Expression and characterization of the intracellular vanilloid receptor (TRPV1) in bronchi from patients with chronic cough. Exp Lung Res 31 (2005) 295-306
23. Morgan C.R., Rodd H.D., Clayton N., Davis J.B., and Boissonade F.M. Vanilloid receptor 1 expression in human tooth pulp in relation to caries and pain. J Orofac Pain 19 (2005) 248-260
24. Tympanidis P., Casula M.A., Yiangou Y., Terenghi G., Dowd P., and Anand P. Increased vanilloid receptor VR1 innervation in vulvodynia. Eur J Pain 8 (2004) 129-133
25. Yiangou Y., Facer P., Dyer N.H., Chan C.L., Knowles C., Williams N.S., and Anand P. Vanilloid receptor 1 immunoreactivity in inflamed human bowel. Lancet 357 (2001) 1338-1339
26. Xu G.Y., Winston J.H., Shenoy M., Yin H., Pendyala S., and Pasricha P.J. Transient receptor potential vanilloid 1 mediates hyperalgesia and is up-regulated in rats with chronic pancreatitis. Gastroenterology 133 (2007) 1282-1292
27. Banerjee B., Medda B.K., Lazarova Z., Bansal N., Shaker R., and Sengupta J.N. Effect of reflux-induced inflammation on transient receptor potential vanilloid one (TRPV1) expression in primary sensory neurons innervating the oesophagus of rats. Neurogastroenterol Motil 19 (2007) 681-691
28. Orliac M.L., Peroni R.N., Abramoff T., Neuman I., Podesta E.J., and dler-Graschinsky E. Increases in vanilloid TRPV1 receptor protein and CGRP content during endotoxemia in rats. Eur J Pharmacol 566 (2007) 145-152
29. Charrua A., Cruz C.D., Cruz F., and Avelino A. Transient receptor potential vanilloid subfamily 1 is essential for the generation of noxious bladder input and bladder overactivity in cystitis. J Urol 177 (2007) 1537-1541
30. Hensellek S., Brell P., Schaible H.G., Brauer R., and Segond von B.G. The cytokine TNFalpha increases the proportion of DRG neurones expressing the TRPV1 receptor via the TNFR1 receptor and ERK activation. Mol Cell Neurosci 36 (2007) 381-391
31. Xue Q., Jong B., Chen T., and Schumacher M.A. Transcription of rat TRPV1 utilizes a dual promoter system that is positively regulated by nerve growth factor. J Neurochem 101 (2007) 212-222
32. Caterina M.J., Schumacher M.A., Tominaga M., Rosen T.A., Levine J.D., and Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389 (1997) 816-824
33. Jia Y., and Lee L.Y. Role of TRPV receptors in respiratory diseases. Biochim Biophys Acta 1772 (2007) 915-927
34. Watanabe N., Horie S., Michael G.J., Spina D., Page C.P., and Priestley J.V. Immunohistochemical localization of vanilloid receptor subtype 1 (TRPV1) in the guinea pig respiratory system. Pulm Pharmacol Ther 18 (2005) 187-197
35. Watanabe N., Horie S., Michael G.J., Keir S., Spina D., Page C.P., and Priestley J.V. Immunohistochemical co-localization of transient receptor potential vanilloid (TRPV)1 and sensory neuropeptides in the guinea-pig respiratory system. Neuroscience 141 (2006) 1533-1543
36. De Swert K.O., and Joos G.F. Extending the understanding of sensory neuropeptides. Eur J Pharmacol 533 (2006) 171-181
37. Hislop A.A., Wharton J., Allen K.M., Polak J.M., and Haworth S.G. Immunohistochemical localization of peptide-containing nerves in human airways: age-related changes. Am J Respir Cell Mol Biol 3 (1990) 191-198
38. Howarth P.H., Springall D.R., Redington A.E., Djukanovic R., Holgate S.T., and Polak J.M. Neuropeptide-containing nerves in endobronchial biopsies from asthmatic and nonasthmatic subjects. Am J Respir Cell Mol Biol 13 (1995) 288-296
39. Davis K.D., Meyer R.A., Turnquist J.L., Filloon T.G., Pappagallo M., and Campbell J.N. Cutaneous pretreatment with the capsaicin analog NE-21610 prevents the pain to a burn and subsequent hyperalgesia. Pain 62 (1995) 373-378
40. Sanico A.M., Philip G., Lai G.K., and Togias A. Hyperosmolar saline induces reflex nasal secretions, evincing neural hyperresponsiveness in allergic rhinitis. J Appl Physiol 86 (1999) 1202-1210
41. Hill R. NK1 (substance P) receptor antagonists - why are they not analgesic in humans?. Trends Pharmacol Sci 21 (2000) 244-246
42. Kudlacz E.M. Combined tachykinin receptor antagonists for the treatment of respiratory diseases. Expert Opin Investig Drugs 7 (1998) 1055-1062
43. Perretti F., and Manzini S. Activation of capsaicin-sensitive sensory fibers modulates PAF-induced bronchial hyperresponsiveness in anesthetized guinea pigs. Am Rev Respir Dis 148 (1993) 927-931
44. Skogvall S., Berglund M., Dalence-Guzman M.F., Svensson K., Jonsson P., Persson C.G., and Sterner O. Effects of capsazepine on human small airway responsiveness unravel a novel class of bronchorelaxants. Pulm Pharmacol Ther 20 (2007) 273-280
45. Helyes Z., Elekes K., Nemeth J., Pozsgai G., Sandor K., Kereskai L., Borzsei R., Pinter E., Szabo A., and Szolcsanyi J. Role of transient receptor potential vanilloid 1 receptors in endotoxin-induced airway inflammation in the mouse. Am J Physiol Lung Cell Mol Physiol 292 (2007) L1173-L1181
46. Jarreau P.H., D'Ortho M.P., Boyer V., Harf A., and quin Mavier I. Effects of capsaicin on the airway responses to inhaled endotoxin in the guinea pig. Am J Respir Crit Care Med 149 (1994) 128-133
47. Hunt J.F., Fang K., Malik R., Snyder A., Malhotra N., Platts-Mills T.A.E., and Gaston B. Endogenous airway acidification. Implications for asthma pathophysiology. Am J Respir Crit Care Med 161 (2000) 694-699
48. Braun A., Nockher W.A., and Renz H. Control of nerve growth and plasticity. Curr Opin Pharmacol 2 (2002) 229-234
49. Christiansen S.C., Proud D., and Cochrane C.G. Detection of tissue kallikrein in the bronchoalveolar lavage fluid of asthmatic subjects. J Clin Invest 79 (1987) 188-197
50. Bradding P., Redington A.E., Djukanovic R., Conrad D.J., and Holgate S.T. 15-Lipoxygenase immunoreactivity in normal and in asthmatic airways. Am J Respir Crit Care Med 151 (1995) 1201-1204
51. Caceres A.I., Brackmann M., Elia M.D., Bessac B.F., del C.D., D'Amours M., Witek J.S., Fanger C.M., Chong J.A., Hayward N.J., et al. A sensory neuronal ion channel essential for airway inflammation and hyperreactivity in asthma. Proc Natl Acad Sci U S A 106 (2009) 9099-9104
52. Fischer A., McGregor G.P., Saria A., Philippin B., and Kummer W. Induction of tachykinin gene and peptide expression in guinea pig nodose primary afferent neurons by allergic airway inflammation. J Clin Invest 98 (1996) 2284-2291
53. Myers A.C., Kajekar R., and Undem B.J. Allergic inflammation-induced neuropeptide production in rapidly adapting afferent nerves in guinea pig airways. Am J Physiol Lung Cell Mol Physiol 282 (2002) L775-L781
54. Chen C.Y., Joad J.P., Bric J., and Bonham A.C. Central mechanisms. I: plasticity of central pathways. Handb Exp Pharmacol 187 (2009) 187-201
55. Sekizawa S., Joad J.P., and Bonham A.C. Substance P presynaptically depresses the transmission of sensory input to bronchopulmonary neurons in the guinea pig nucleus tractus solitarii. J Physiol 552 (2003) 547-559
56. Birder L.A., Kanai A.J., De Groat W.C., Kiss S., Nealen M.L., Burke N.E., Dineley K.E., Watkins S., Reynolds I.J., and Caterina M.J. Vanilloid receptor expression suggests a sensory role for urinary bladder epithelial cells. Proc Natl Acad Sci U S A 98 (2001) 13396-13401
57. Veronesi B., Oortgiesen M., Roy J., Carter J.D., Simon S.A., and Gavett S.H. Vanilloid (capsaicin) receptors influence inflammatory sensitivity in response to particulate matter. Toxicol Appl Pharmacol 169 (2000) 66-76
58. Agopyan N., Head J., Yu S., and Simon S.A. TRPV1 receptors mediate particulate matter-induced apoptosis. Am J Physiol Lung Cell Mol Physiol 286 (2004) L563-L572
59. Reilly C.A., Taylor J.L., Lanza D.L., Carr B.A., Crouch D.J., and Yost G.S. Capsaicinoids cause inflammation and epithelial cell death through activation of vanilloid receptors. Toxicol Sci 73 (2003) 170-181
60. Denda M., Fuziwara S., Inoue K., Denda S., Akamatsu H., Tomitaka A., and Matsunaga K. Immunoreactivity of VR1 on epidermal keratinocyte of human skin. Biochem Biophys Res Commun 285 (2001) 1250-1252
61. Inoue K., Koizumi S., Fuziwara S., Denda S., Inoue K., and Denda M. Functional vanilloid receptors in cultured normal human epidermal keratinocytes. Biochem Biophys Res Commun 291 (2002) 124-129
62. Southall M.D., Li T., Gharibova L.S., Pei Y., Nicol G.D., and Travers J.B. Activation of epidermal vanilloid receptor-1 induces release of proinflammatory mediators in human keratinocytes. J Pharmacol Exp Ther 304 (2003) 217-222
63. Kido M.A., Muroya H., Yamaza T., Terada Y., and Tanaka T. Vanilloid receptor expression in the rat tongue and palate. J Dent Res 82 (2003) 393-397
64. Biro T., Maurer M., Modarres S., Lewin N.E., Brodie C., Acs G., Acs P., Paus R., and Blumberg P.M. Characterization of functional vanilloid receptors expressed by mast cells. Blood 91 (1998) 1332-1340
65. Seki N., Shirasaki H., Kikuchi M., and Himi T. Capsaicin induces the production of IL-6 in human upper respiratory epithelial cells. Life Sci 80 (2007) 1592-1597
66. Riccio M.M., Matsumoto T., Adcock J.J., Douglas G.J., Spina D., and Page C.P. The effect of 15-HPETE on airway responsiveness and pulmonary cell recruitment in rabbits. Br J Pharmacol 122 (1997) 249-256